BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 8178868)

  • 1. The process of carcinogenesis for endometrial adenocarcinoma could be short: development of a malignancy after endometrial ablation.
    Ramey JW; Koonings PP; Given FT; Acosta AA
    Am J Obstet Gynecol; 1994 May; 170(5 Pt 1):1370-1. PubMed ID: 8178868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endometrial carcinoma after endometrial resection for dysfunctional uterine bleeding.
    Sagiv R; Ben-Shem E; Condrea A; Glezerman M; Golan A
    Obstet Gynecol; 2005 Nov; 106(5 Pt 2):1174-6. PubMed ID: 16260560
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thin-layer cytology and histopathology in the evaluation of abnormal uterine bleeding.
    Garcia F; Barker B; Davis J; Shelton T; Harrigill K; Schalk N; Meyer J; Hatch K
    J Reprod Med; 2003 Nov; 48(11):882-8. PubMed ID: 14686021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endometrial curettage in abnormal uterine bleeding and efficacy of progestins for control in cases of hyperplasia.
    Mesci-Haftaci S; Ankarali H; Yavuzcan A; Caglar M
    Asian Pac J Cancer Prev; 2014; 15(8):3737-40. PubMed ID: 24870785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endometrial ablation. A report of four cases.
    Gimpelson RJ; Lentz RD
    J Reprod Med; 1993 Aug; 38(8):592-4. PubMed ID: 8410862
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of coexisting endometrial carcinoma in case of atypical endometrial hyperplasia diagnosed on total hysteroscopic resection.
    Pivano A; Crochet P; Carcopino X; Cravello L; Boubli L; Agostini A
    Eur J Obstet Gynecol Reprod Biol; 2016 Aug; 203():210-3. PubMed ID: 27343737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endometrial biopsy. Finding the cause of uterine bleeding.
    Mayo Clin Health Lett; 2001 Aug; 19(8):6. PubMed ID: 11475596
    [No Abstract]   [Full Text] [Related]  

  • 8. Hysteroscopy with selective endometrial sampling after unsuccessful dilatation and curettage in diagnosis of symptomatic endometrial cancer and endometrial hyperplasias.
    Spiewankiewicz B; Stelmachów J; Sawicki W; Kietlinska Z
    Eur J Gynaecol Oncol; 1995; 16(1):26-9. PubMed ID: 7744113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcervical endometrial resection when hysterectomy is dangerous.
    Chacko N; Seshadri L; Ninan S
    Natl Med J India; 1995; 8(2):63-4. PubMed ID: 7735062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison the Diagnostic Value of Dilatation and Curettage Versus Endometrial Biopsy by Pipelle--a Clinical Trial.
    Sanam M; Majid MM
    Asian Pac J Cancer Prev; 2015; 16(12):4971-5. PubMed ID: 26163624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effectiveness of the Masterson curette in sampling the endometrial cavity.
    Reddington L; Hernandez E; Balsara G; Hughes D; Anderson L; Heller PB
    J Natl Med Assoc; 1995 Dec; 87(12):877-80. PubMed ID: 8558620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prognostic and therapeutic implications of cytologic atypia in patients with endometrial hyperplasia.
    Hunter JE; Tritz DE; Howell MG; DePriest PD; Gallion HH; Andrews SJ; Buckley SB; Kryscio RJ; van Nagell JR
    Gynecol Oncol; 1994 Oct; 55(1):66-71. PubMed ID: 7959270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Not so benign endometrial hyperplasia: endometrial cancer after endometrial ablation.
    Gimpelson RJ
    J Am Assoc Gynecol Laparosc; 1997 Aug; 4(4):507-11. PubMed ID: 9224590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical value of dilatation and curettage for abnormal uterine bleeding.
    Tabata T; Yamawaki T; Ida M; Nishimura K; Nose Y; Yabana T
    Arch Gynecol Obstet; 2001 Jan; 264(4):174-6. PubMed ID: 11205702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natural history of endometrial hyperplasia. Study of 77 patients.
    Tabata T; Yamawaki T; Yabana T; Ida M; Nishimura K; Nose Y
    Arch Gynecol Obstet; 2001 May; 265(2):85-8. PubMed ID: 11409481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adenocarcinoma diagnosed at endometrial ablation.
    Steed HL; Scott JZ
    Obstet Gynecol; 2001 May; 97(5 Pt 2):837-9. PubMed ID: 11336774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospective comparison of biopsy results from curettage and hysteroscopy in postmenopausal uterine bleeding.
    Lee DO; Jung MH; Kim HY
    J Obstet Gynaecol Res; 2011 Oct; 37(10):1423-6. PubMed ID: 21651668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endometrial adenocarcinoma following endometrial ablation for postmenopausal bleeding.
    Horowitz IR; Copas PR; Aaronoff M; Spann CO; McGuire WP
    Gynecol Oncol; 1995 Mar; 56(3):460-3. PubMed ID: 7705687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Transvaginal echography in patients with postmenopausal metrorrhagia].
    Taviani A; Braccini S; Toniazzi P; Pantani P; Costamagna V; Gambini G; Pancanti V
    Minerva Ginecol; 1995 Sep; 47(9):369-72. PubMed ID: 8545037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histopathologic correlation of dilatation and currettage and hysterectomy specimens in patients with postmenopausal bleeding.
    Saygili H
    Eur J Gynaecol Oncol; 2006; 27(2):182-4. PubMed ID: 16620067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.